PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity, and health related quality of life after cancer occurring among children and adolescents

Our latest paper, published in the European Journal of Cancer, describes the scientific rationale for the PanCareLIFE project (103:227 – 237 (2018)). Read more here!

Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies

The WP3 team has published their protocol paper on two fertility studies completed as part of PanCareLIFE: Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE) in JMIR Res Protoc. (2018 14;7(9):e10824). You can read the full open access paper here!

Survivor Day in Köln

On 29 Sept, over 200 young adult survivors of cancer gathered in Köln for the first Survivor Day of the German Childhood Cancer Foundation (DKS). PanCareLIFE was represented by Dr. Gabriele Calaminus, Dr. Desiree Grabow, Prof. Dr. Thorsten Langer, Prof. Dr. Anja Borgmann-Staudt and Katja Baust. In Germany, around 50,000 survivors are considered cured, and the DKS […]

PanCare Research Projects in the German Media

The PanCare network has been involved in two EU-funded research projects (PanCareLIFE, PanCareSurFup) to advance knowledge of late effects and advance survivorship care for childhood cancer survivors. Deutschlandfunk Kultur spoke to cancer survivor Christine and PanCareLIFE coordinator Dr. Peter Kaatsch to learn more about the impact of European-funded research. The impact of Brexit on European research was also […]

Read all the latest news from the Childhood Cancer Survivor Study

Coordinated through St. Jude Children’s Research Hospital, the Childhood Cancer Survivor Study cohort has been assembled through the efforts of 31 participating centers in the United States and Canada. You can learn more about an important new tool that the Long Term Follow Up (LTFU) Study have developed to help survivors of childhood cancer, and […]